Antibodies having specificity for BTN2 and uses thereof
US11572409B2 · kind B2 · utility
0Cited by
2References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 21, 2018 |
| Grant date | Feb 7, 2023 |
| Priority date | — |
| Expiry date | Apr 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies having specificity for BTN2 and uses thereof, in particular for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.